Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance
Siegfried Kasper, Wiesław Jerzy Cubała, Andrea Fagiolini, et al.
The World Journal of Biological Psychiatry (2020), pp. 1-15
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Perioperative Adjunctive Esketamine for Postpartum Depression Among Women Undergoing Elective Cesarean Delivery
Yu Chen, Yu Guo, Han Wu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 3, pp. e240953-e240953
Open Access | Times Cited: 22
Perspectives for therapy of treatment‐resistant depression
Mariusz Papp, Wiesław Jerzy Cubała, Łukasz Świȩcicki, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 17, pp. 4181-4200
Open Access | Times Cited: 63
Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis
Alessandro Rodolico, Pierfelice Cutrufelli, Antonio Di Francesco, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 10
Is there a risk of esketamine misuse in clinical practice?
Carlos Roncero, M. Merizalde Torres, Néstor Szerman, et al.
Therapeutic Advances in Drug Safety (2025) Vol. 16
Open Access | Times Cited: 1
Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review
Matteo Di Vincenzo, Vassilis Martiadis, Bianca Della Rocca, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 8
Psychedelic treatments for mental health conditions pose challenges for informed consent
Carolina Seybert, Gonçalo Cotovio, Luís Madeira, et al.
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2167-2170
Closed Access | Times Cited: 16
Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel
Giuseppe Maina, Marina Rossato Adami, G. Ascione, et al.
Annals of General Psychiatry (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Overview of treatment-resistant depression
Cheng‐Ta Li
Progress in brain research (2023), pp. 1-23
Closed Access | Times Cited: 15
Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy
P. Baldinger, Marie Spies, Ina Bozic, et al.
Wiener klinische Wochenschrift (2024)
Closed Access | Times Cited: 5
Strategies for the use of Ginkgo biloba extract, EGb 761 ® , in the treatment and management of mild cognitive impairment in Asia: Expert consensus
Nagaendran Kandiah, Yee Fai Chan, Christopher Chen, et al.
CNS Neuroscience & Therapeutics (2020) Vol. 27, Iss. 2, pp. 149-162
Open Access | Times Cited: 33
Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review
Jolien K. E. Veraart, Sanne Y. Smith-Apeldoorn, Iris M Bakker, et al.
The International Journal of Neuropsychopharmacology (2021) Vol. 24, Iss. 10, pp. 808-831
Open Access | Times Cited: 30
The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis
Muhammad Youshay Jawad, Joshua D. Di Vincenzo, Felicia Ceban, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 841-852
Open Access | Times Cited: 22
The mechanistic basis for the rapid antidepressant-like effects of ketamine: From neural circuits to molecular pathways
Li Ren
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 129, pp. 110910-110910
Open Access | Times Cited: 11
Effect of intraoperative injection of esketamine on postoperative analgesia and postoperative rehabilitation after cesarean section
Hongzhuan Chen, Yi Gao, Keke Li, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 28, pp. 6195-6203
Open Access | Times Cited: 4
Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial
Anna Höflich, Christoph Kraus, Ruth M. Pfeiffer, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
Gernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 272, Iss. 4, pp. 715-727
Open Access | Times Cited: 18
Effects of suggestion therapy on mood and sleep quality in middle-aged women with depression
Yuan Jiang, Ke Xia, Zhong Lin
World Journal of Psychiatry (2025) Vol. 15, Iss. 3
Closed Access
Person-centred care during treatment with nasal esketamine — a qualitative study
Lina Klysing, Ingrid Larsson, Katrin Häggström Westberg
BMC Nursing (2025) Vol. 24, Iss. 1
Open Access
Treatment-resistant or difficult-to-treat depression: a consensus on the pharmacotherapy challenges and considerations for the health care system in Greece
Kyriakos Souliotis, Christina Golna, Myrto Samara, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Treatment-resistant depression and intranasal esketamine: Spanish clinical consensus on practical aspects
Josep Antoni Ramos‐Quiroga, Fernando Mora, Silvia Arostegui, et al.
The European Journal of Psychiatry (2025) Vol. 39, Iss. 3, pp. 100313-100313
Open Access
Multi-agent norm perception and induction in distributed healthcare
Chao Li, Olga Petruchik, Elizaveta Grishanina, et al.
Journal of Biomedical Informatics (2025), pp. 104835-104835
Closed Access
Effects of bilateral sequential theta-burst stimulation on 5-HT1A receptors in the dorsolateral prefrontal cortex in treatment-resistant depression: a proof-of-concept trial
Matej Murgaš, Jakob Unterholzner, Peter Stöhrmann, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Altered Fecal Metabolites and Colonic Glycerophospholipids Were Associated With Abnormal Composition of Gut Microbiota in a Depression Model of Mice
Xue Gong, Cheng Huang, Xun Yang, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 19
The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
Alina Wilkowska, Wiesław Jerzy Cubała
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14605-14605
Open Access | Times Cited: 14
Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
Journal of Psychiatric Research (2021) Vol. 141, pp. 167-175
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top